Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investment Strategy
Stock markets
Eisai Co Ltd
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Apple Inc
stocks
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Eli Lilly and Co
Johnson & Johnson
Bristol/Myers Squibb Co
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Pharmaceuticals
Morgan Stanley
Eli Lilly and Co
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Technology
Eli Lilly and Co
Alphabet Inc
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Personal finance
Weight loss diets
Social issues
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Eli Lilly and Co
Pharmaceuticals
US: News
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Novo Nordisk A/S
Chugai Pharmaceutical Co Ltd
Exchange/traded funds
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Eli Lilly and Co
Health & Science
Health care industry
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Biotechnology
Business
Companies
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
Investment strategy
Stock Picks
Investing
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Health care industry
Health & Science
Investment strategy
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health care industry
Health & Science
Science
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Biotechnology
Business
Carmot Therapeutics Inc
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Alphabet Inc
Novo Nordisk A/S
Science
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Novo Nordisk A/S
Science
Biotechnology
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
Eli Lilly and Co
Tesla Inc
AI / Artificial Intelligence
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Novo Nordisk A/S
Health & Science
Health care industry
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Companies
Health & Science
Health care industry
From
CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
May 05, 2024
Tags
NVIDIA Corp
Drug trials
Technology
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Business News
Novo Nordisk A/S
Business
From
CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
May 03, 2024
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Europe Markets
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Biotech and Pharmaceuticals
Breaking news
Business
From
CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
April 30, 2024
Tags
Biotech and Pharmaceuticals
Breaking news
Earnings
From
CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
Tags
Amazon/com Inc
Business News
McDonald's Corp
From
CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
April 26, 2024
Tags
McDonald's Corp
Amazon/com Inc
Business News
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Molson Coors Beverage Co
Health care industry
Food Retail
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Biotech and Pharmaceuticals
Breaking news
Biotechnology
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Business
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.